Status:
UNKNOWN
Automated Surveillance, Alert, and Rapid Diagnosis of Thrombotic Microangiopathies: the ASARD-TMA Study
Lead Sponsor:
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Conditions:
Thrombotic Microangiopathies
Eligibility:
All Genders
18-100 years
Brief Summary
Recently a pilot study was conducted to evaluate the impact of an electronic alert (e-alert) triggered by the automated algorithm in the efficiency and rapidity in TMA patients' identification in our ...
Eligibility Criteria
Inclusion
- Patients admitted to the Emergency ward or inpatients of the involved Hospitals with suspicion of TMA:
- Based on the clinical evaluation of the care physicians
- Based on the alerts issued by the automated algorithm
Exclusion
- Patients with a predictive probability of TMA \< 90% (6) according to the diagnostic algorithm
Key Trial Info
Start Date :
October 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 1 2025
Estimated Enrollment :
29 Patients enrolled
Trial Details
Trial ID
NCT05996679
Start Date
October 1 2023
End Date
October 1 2025
Last Update
August 18 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.